C21H18BrNO3
Neat
412.29
-20°C
Room Temperature
881639-98-1; RefChem:879191; rel-1-((3aR, 4S, 9bS)-4-(6-Bromo-1, 3-benzodioxol-5-yl)-3a, 4, 5, 9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone; G-1; LNS-8801; 1-[(3aS, 4R, 9bR)-4-(6-bromo-1, 3-benzodioxol-5-yl)-3a, 4, 5, 9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone; LNS8801; 1-(4-(6-Bromobenzo[1, 3]dioxol-5-yl)-3a, 4, 5, 9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone; TFS4QE36ZG; Y3V5BV7OKM; G 1 (Anti-tumor agent); CHEMBL569766; ML051; 1-((3aS, 4R, 9bR)-4-(6-bromobenzo[d][1, 3]dioxol-5-yl)-3a, 4, 5, 9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)ethanone; 925419-53-0; Ethanone, 1-((3aS, 4R, 9bR)-4-(6-bromo-1, 3-benzodioxol-5-yl)-3a, 4, 5 and 9b-tetrahydro-3H-cyclopenta(C)quinolin-8-yl)-; SR-01000506928; GPER agonist; G-1 cpd; UNII-TFS4QE36ZG
1-[(3aS, 4R, 9bR)-4-(6-bromo-1, 3-benzodioxol-5-yl)-3a, 4, 5 and 9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone
InChI=1S/C21H18BrNO3/c1-11(24)12-5-6-18-15(7-12)13-3-2-4-14(13)21(23-18)16-8-19-20(9-17(16)22)26-10-25-19/h2-3,5-9,13-14,21,23H,4,10H2,1H3/t13-,14+,21-/m1/s1